FDA inspection
Rubicon Research Limited: FDA inspection ending Jan 27, 2023
FDA inspection 1195651 · Voluntary Action Indicated (VAI) · Thane
Key facts
| Inspection ID | 1195651 |
|---|---|
| Firm | Rubicon Research Limited |
| FEI number | 3008252295 |
| Address | Plot No K-30/4 & K30/5, Midc, Additional Ambernath Area |
| City | Thane |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Jan 27, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data